PHOTO
Abu Dhabi, United Arab Emirates – Effective 27 July, Etihad Airways will resume passenger flights from Abu Dhabi, the capital of the United Arab Emirates, to Shanghai, China. The service will operate with an initial weekly flight using a Boeing 777-300ER, featuring Business and Economy cabins.
Robin Kamark, Etihad Aviation Group Chief Commercial Officer, said: “We are delighted to announce the resumption of scheduled services to China, as we gradually return to more destinations on our global network, supporting the recovery of economic and social activities worldwide. Our priority now is to build the network back up on markets that have opened up and to provide a secure and hygienic flying environment across the entire guest journey.
“The restarting of passenger services between Abu Dhabi and Shanghai will cater to the large demand from business travellers in the UAE, China, and other economies in the Middle East and Africa. We are tremendously grateful to our customers and partners for their continued loyalty and we stand ready fly more frequencies to China when possible."
Flight Schedule, effective 27 July (all times local)
Flight | Departure | Time | Arrival | Time | Aircraft | Frequency |
EY 862 | Abu Dhabi | 01:00 | Shanghai | 13:50 | Boeing 777-300ER | Monday |
EY 867 | Shanghai | 23:40 | Abu Dhabi | 05:10 +1 | Boeing 777-300ER | Tuesday |
Those wishing to book are advised to visit www.etihad.com to view their options, and to remain informed on the appropriate entry regulations at their end destination. Flights are also available for booking through the mobile app, by calling the Etihad Airways Contact Centre on +971 600 555 666 (UAE), 400 8822 050 (Mainland China), or through a local or online travel agency. A list of other local Etihad contact centres is available at www.etihad.com/contacts.
Important note
Guests travelling on Etihad Airways flights to China will be required to show a negative COVID-19 PCR test result received within 72 hours prior to departure from Abu Dhabi, or from their departure airport if they are transferring from other cities via Abu Dhabi.
In the UAE, guests travelling to all Etihad Airways destinations, including Shanghai, can make use of a new home testing service introduced in collaboration with Mediclinic. For a fee, UAE-based travellers can book a convenient COVID-19 PCR test at their home, or at a Mediclinic facility in Abu Dhabi, Al Ain, or Dubai, prior to their travel. The service is also convenient for those crossing the Abu Dhabi border from other emirates to reach Abu Dhabi International Airport.
Simple and convenient booking process:
- Guest books a flight at etihad.com.
- Guest contacts Mediclinic to arrange an appointment.
Visit: www.mediclinic.ae
Call: 800 2022
Email: etihad@mediclinic.ae
The return to a larger network of international flights is being greatly supported by the Etihad Wellness sanitisation and safety programme, which ensures the highest standards of hygiene are maintained at every stage of the customer journey. This includes specially trained Wellness Ambassadors, a first in the industry, who have been introduced by the airline to provide essential travel health information and care on the ground and on every flight, so guests can fly with greater ease and peace of mind.
More information on the stringent measures being taken by Etihad Airways to provide a healthy and hygienic travel experience is available at www.etihad.com/wellness.
For further details:
Duty Media Officer
Etihad Airways
Tel: +97150 818 9596
Email: dutymediaofficer@etihad.ae
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
